ATAT1-dependent microtubule acetylation drives pancreatic tumorigenesis through DNMT1-mediated regulation of NDRG4

Microtubule (MT) acetylation is frequently elevated in cancer and associated with poor prognosis. Alpha-tubulin acetyltransferase 1 (ATAT1), the principal enzyme responsible for this modification, has therefore emerged as a potential therapeutic target. However, which cancer types depend on ATAT1 activity and are selectively vulnerable to its inhibition remains unclear. Here, using a phospho-specific marker of ATAT1 activity, we identify pancreatic ductal adenocarcinoma (PDAC) as an ATAT1-dependent malignancy. ATAT1 activity is elevated in human PDAC and genetically engineered mouse models, emerging during pancreatic intraepithelial neoplasia and persisting in a substantial subset of tumors. Genetic inactivation or pharmacologic inhibition of ATAT1 suppresses PDAC cell growth, reduces orthotopic tumor burden, and markedly inhibits tumor initiation in KPC mice without overt toxicity. Mechanistically, ATAT1-dependent MT acetylation sustains Akt signaling, resulting in inhibitory phosphorylation of GSK3β and stabilization of the DNA methyltransferase DNA methyltransferase 1 (DNMT1). Elevated DNMT1 promotes repression of tumor suppressor genes, including NDRG4, whereas inhibition of ATAT1 or DNMT1 restores NDRG4 expression and impairs tumor growth. Together, these findings identify a previously unrecognized ATAT1-Akt-GSK3β-DNMT1 signaling axis linking cytoskeletal acetylation to NDRG4 repression and reveal ATAT1 as a therapeutic vulnerability during the early stages of pancreatic tumorigenesis.

Authors

Institutions

Publication Details

Journal
Proceedings of the National Academy of Sciences
Published
2026-11-18
DOI
https://doi.org/10.1073/pnas.2604077123
Primary Topic
Microtubule and mitosis dynamics
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

ATAT1-dependent microtubule acetylation drives pancreatic tumorigenesis through DNMT1-mediated regulation of NDRG4

Julia Podgorski, Nam Y. Lee, Paul R. Langlais, Christopher Cartmell et al.
1 links
Proceedings of the National Academy of Sciences
Microtubule and mitosis dynamics
article

ATAT1-dependent microtubule acetylation drives pancreatic tumorigenesis through DNMT1-mediated regulation of NDRG4

Julia Podgorski, Nam Y. Lee, Paul R. Langlais, Christopher Cartmell, Hannah R. Ortiz, Nathan A. Ellis, Paola Cruz Flores, Karthikeyan Mythreye, Atsushi Ishii, Aaron Ramonett, Monique R. Archuleta
article en

Abstract

Microtubule (MT) acetylation is frequently elevated in cancer and associated with poor prognosis. Alpha-tubulin acetyltransferase 1 (ATAT1), the principal enzyme responsible for this modification, has therefore emerged as a potential therapeutic target. However, which cancer types depend on ATAT1 activity and are selectively vulnerable to its inhibition remains unclear. Here, using a phospho-specific marker of ATAT1 activity, we identify pancreatic ductal adenocarcinoma (PDAC) as an ATAT1-dependent malignancy. ATAT1 activity is elevated in human PDAC and genetically engineered mouse models, emerging during pancreatic intraepithelial neoplasia and persisting in a substantial subset of tumors. Genetic inactivation or pharmacologic inhibition of ATAT1 suppresses PDAC cell growth, reduces orthotopic tumor burden, and markedly inhibits tumor initiation in KPC mice without overt toxicity. Mechanistically, ATAT1-dependent MT acetylation sustains Akt signaling, resulting in inhibitory phosphorylation of GSK3β and stabilization of the DNA methyltransferase DNA methyltransferase 1 (DNMT1). Elevated DNMT1 promotes repression of tumor suppressor genes, including NDRG4, whereas inhibition of ATAT1 or DNMT1 restores NDRG4 expression and impairs tumor growth. Together, these findings identify a previously unrecognized ATAT1-Akt-GSK3β-DNMT1 signaling axis linking cytoskeletal acetylation to NDRG4 repression and reveal ATAT1 as a therapeutic vulnerability during the early stages of pancreatic tumorigenesis.

Proceedings of the National Academy of SciencesVol. 123(47)
University of Arizona (US), University of Alabama at Birmingham (US), Cellular Research (United States) (US), University of Arizona Cancer Center (US)
University of Arizona Cancer Center, University of Arizona, National Institutes of Health, National Cancer Institute
Good health and well-being
Microtubule and mitosis dynamics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon